These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2117173)

  • 1. Management of chronic airway obstruction: theophylline--is it still necessary?
    Ukena D; Sybrecht GW
    Lung; 1990; 168 Suppl():627-33. PubMed ID: 2117173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of asthma and chronic airflow limitation: are methylxanthines obsolete?
    Newhouse MT; Lam A
    Lung; 1990; 168 Suppl():634-41. PubMed ID: 2117174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Theophylline: new information about a proven drug. The dual effect in therapy of bronchial asthma].
    Ukena D; Keller A; Sybrecht GW
    Med Klin (Munich); 1994 Dec; 89(12):668-74. PubMed ID: 7870002
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
    Chrystyn H; Mulley BA; Peake MD
    BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theophylline--at 100 years old into its 4th life].
    Nolte D
    Med Klin (Munich); 1994 Dec; 89(12):675-6. PubMed ID: 7870003
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chronic theophylline treatment on the methacholine dose-response curve in allergic asthmatic subjects.
    Page CP; Cotter T; Kilfeather S; Sullivan P; Spina D; Costello JF
    Eur Respir J; 1998 Jul; 12(1):24-9. PubMed ID: 9701409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of allergen-induced airway obstruction and bronchial hyperresponsiveness in the allergic rabbit by theophylline aerosol.
    Ali S; Mustafa SJ; Metzger WJ
    Agents Actions; 1992 Nov; 37(3-4):168-70. PubMed ID: 1295361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to large doses of salbutamol and theophylline in patients with chronic obstructive pulmonary disease.
    Filuk RB; Easton PA; Anthonisen NR
    Am Rev Respir Dis; 1985 Oct; 132(4):871-4. PubMed ID: 4051322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of theophylline on airway inflammation.
    Pauwels R
    Chest; 1987 Jul; 92(1 Suppl):32S-37S. PubMed ID: 3297525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Principles of theophylline therapy in obstructive respiratory diseases].
    Ukena D; Sybrecht GW
    Pneumologie; 1992 Feb; 46(2):49-51. PubMed ID: 1549553
    [No Abstract]   [Full Text] [Related]  

  • 12. Theophylline in stable chronic airflow obstruction. A reappraisal.
    Dull WL; Alexander MR
    Arch Intern Med; 1984 Dec; 144(12):2399-401. PubMed ID: 6391407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of theophylline in chronic obstructive lung disease.
    Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline in asthma and COPD: changing perspectives and controversies.
    Poe RH; Utell MJ
    Geriatrics; 1991 Apr; 46(4):55-6, 61-5. PubMed ID: 2010095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of anticholinergic bronchodilators in adult asthma and chronic obstructive pulmonary disease.
    Chapman KR
    Lung; 1990; 168 Suppl():295-303. PubMed ID: 2143551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a hand-held spirometer as a monitoring tool in chronic theophylline therapy.
    Mikhail MN; Catania PN
    Drug Intell Clin Pharm; 1987 Jun; 21(6):502-4. PubMed ID: 3608796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of oxidative stress in asthma and COPD: potential inhibitory effect of theophylline.
    Tsukagoshi H; Shimizu Y; Iwamae S; Hisada T; Ishizuka T; Iizuka K; Dobashi K; Mori M
    Respir Med; 2000 Jun; 94(6):584-8. PubMed ID: 10921764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylxanthine therapy and reversible airway obstruction.
    McFadden ER
    Am J Med; 1985 Dec; 79(6A):1-4. PubMed ID: 4083294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease.
    Bleecker ER; Britt EJ
    Am J Med; 1991 Oct; 91(4A):24S-27S. PubMed ID: 1835291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.